Skip to content
User

Seth Klarman

Baupost Group

Seth Klarman Celgene Corp stake

total: 272

Baupost Group CELG trades

Total transactions:
2
New positions:
1
Sold out:
1
Held since:
2019 Q1
Held for:
1 quarter
Latest activity:
2019 Q2
According to 2026 Q2 report, Seth Klarman doesn't hold any Celgene Corp (CELG) shares. To date, the estimated cost basis is nearly $94.34 for "buy" trades and estimated average "sell" price is $94.34. Baupost Group first purchased CELG in 2019 Q1, initially acquiring about 4.00M shares. Since the initial investment in Celgene Corp (CELG), Baupost Group has made 1 more transaction.

When did Seth Klarman sell Celgene Corp (CELG)?

Seth Klarman sold off the entire Celgene Corp (CELG) position in 2019 Q2.

When did Seth Klarman buy Celgene Corp (CELG)?

Seth Klarman first invested in Celgene Corp (CELG) in 2019 Q1 at the reported quarter-end price of $94.34 per share.

What's the cost basis of Baupost Group's CELG stake?

The estimated cost basis for Celgene Corp (CELG) stake is around $94.34 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$94.34
Weighted AVG sell price:
$94.34

Seth Klarman's historical trades in Celgene Corp

2 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2019 Q2
0.00%
$94.34
-100% (-4,000,000)
2019 Q1
3.17%
$94.34
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.